300+ investors in your industry, stage, and region Get
Any industry
Video Games
Hospitality
EdTech
Restaurants
Google
Construction
Photography
Cryptocurrency
Clean Energy
CleanTech
Big Data
Email
Artificial Intelligence
Social Impact
SaaS
Energy
Mobile
Consumer
Health Care
Enterprise Software
Local
Platforms
InsurTech
Travel
Film
Oil and Gas
Retail
Payments
Marketplace
Fitness
Organic Food
Machine Learning
Agriculture (AgTech)
Gaming
Facebook
Blockchain
B2B
Social Network
Medical Device
Education
Wellness
Sports
Automotive
eSports
Legal
Software
Biotechnology
Renewable Energy
Crowdfunding
Venture Capital
Social
Infrastructure
Beauty
Fashion
Climate
LGBT
Cannabis
Celebrity
Life Science
Food and Beverage
Publishing
Mobile Apps
Wine and Spirits
Music
Art
Real Estate
Sporting Goods
Recruiting
Manufacturing
FinTech
Finance
Digital Media
Social Media
Financial Services
Franchise
Non Profit
Internet
Mobile Advertising
Android
Proptech
Impact
Sustainability
Hardware
Biotech
Transportation
Enterprise
Community
Media (Entertainment)
Web3
Medical
Theatre
Any country
Afghanistan
Greece
United Kingdom
Thailand
United Arab Emirates
Andorra
Benin
South Korea
Japan
Burkina Faso
Africa
Singapore
Brazil
LATAM
Gibraltar
Egypt
Taiwan
Zimbabwe
Tunisia
Sweden
Oceania
Hong Kong
Nigeria
Togo
Croatia
Iran
Guinea
Haiti
Kyrgyzstan
Norway
Lesotho
Liberia
Isle of Man
Malawi
Mexico
Nepal
Madagascar
Russian Federation
Sudan
Pakistan
Tajikistan
Zambia
Romania
Oman
Poland
Puerto Rico
Cameroon
Guernsey
Colombia
China
Armenia
Costa Rica
Kenya
Czech Republic
Kuwait
Marshall Islands
Luxembourg
Malta
Mozambique
Namibia
Mauritius
Nicaragua
Panama
Serbia
Uzbekistan
New Zealand
Australia
Saudi Arabia
Sri Lanka
Jamaica
Guatemala
Morocco
Switzerland
Kazakhstan
Cayman Islands
Venezuela
Myanmar
Turkey
Uganda
Uruguay
Moldova
Seychelles
Botswana
Canada
Paraguay
South Africa
France
Ireland
Denmark
Georgia
Ghana
Iraq
Latvia
Malaysia
Mali
Philippines
Portugal
Rwanda
El Salvador
Sierra Leone
Tanzania
Senegal
United States
India
Germany
Middle East
Indonesia
Asia
Dominican Republic
Bermuda
Albania
Spain
Argentina
Europe
Qatar
Angola
Cyprus
Bangladesh
Barbados
Belgium
Jordan
Ethiopia
Austria
Azerbaijan
Bulgaria
Faroe Islands
Jersey
Bahrain
Ecuador
Bolivia
Estonia
Belize
Algeria
Italy
Belarus
Finland
Bahamas
Hungary
Grenada
Israel
Lithuania
Liechtenstein
Honduras
Iceland
Cambodia
Lebanon
Mongolia
Peru
Slovenia
San Marino
Ukraine
Chile
Vietnam
Angel Investors
VC Funds
All Investors
Access Full Database - Free Forever
Open database
FCA Venture Partners, VC Fund

FCA Venture Partners

VC Fund

Brentwood, United States

FCA Venture Partners is a VC fund in Brentwood focused on Health Care and Software. Founded in 1996, FCA Venture Partners has a long history of investing in successful healthcare entrepreneurs. The firm is passionate about building sustainable businesses and providing strategic value to their portfolio companies. FCA invests $3-6M in fast growing healthcare companies making processes in the industry faster, better, and cheaperwhile improving the quality of care and the patient experience. With its location in Nashville, roots with Clayton Associates and the McWhorter Family, and deep involvement in the growth of the U.S. healthcare community, FCA Venture Partners is poised to take advantage of disruptive opportunities that help move healthcare forward.

Total investments:
92
Last investment:
Lead investor:
40%
Fund size:
$60M
Last fund:

Last updated:

Industries FCA Venture Partners invests in

Health CareSoftwareMedicalInformation TechnologyMedical Device

Stages FCA Venture Partners invests in

Series ASeries BFunding RoundSeedConvertible Note

Countries FCA Venture Partners invests in

United States

Round sizes

Series A $3M–$17MSeries B $3M–$27M

Contacts

NameEmailPhoneSocials
See all 8 contacts →

Sign up to unlock verified contacts

Unlock Contacts

Round size

Series A
$3M–$17M
Series B
$3M–$27M

Investment Focus

Industry

  • Health Care 43 (47%)
  • Software 19 (21%)
  • Medical 14 (15%)
  • Information Technology 9 (10%)
  • Medical Device 8 (9%)
See all 77 industries →

Stage

  • Series A 31 (34%)
  • Series B 14 (15%)
  • Funding Round 14 (15%)
  • Seed 7 (8%)
  • Convertible Note 5 (5%)
See all 8 stages →

Team

NameTitleInvestmentsLinksEmail
Andrew Bouldin
Andrew Bouldin Partner
Partner Total investments: 3
Find email
George Curran
George Curran Associate
Associate Total investments: 0 Find email
John R. Burch
John R. Burch Managing Partner
Managing Partner Total investments: 7
Find email
Matthew King
Matthew King Managing Partner
Managing Partner Total investments: 22
Find email
Nancy S. Allen
Nancy S. Allen Partner & CFO
Partner & CFO Total investments: 0
Find email
See all 8 team members →

Investments

CompanyDescriptionRoundLinks
Billions of dollars of prescription medications are wasted each year due to expiring inventory, overstock issues and the like. And, all too often patients can’t find the medications they need, even when the drug might be at another pharmacy close by.InStockRx solves this problem. We provide: a self-populating marketplace where pharmacies canbuy and sell with each other, a robust inventory analytics SaaS tool that pinpoints inventory issues and an in-stock drug search engine so pharmacies can easily find the drugs they need on the marketplace. Pharmacies buy and sell with each other today, but just don't have the right tools. With InStockRx, they do. $5M / Series A / Jul 01, 2026
BranchLab makes healthcare advertising better so that people may find the best healthcare options. $28.8M / Series A / May 13, 2026
Coral Care is a technology company for in-person specialized pediatric developmental healthcare. It aims to improve access to pediatric developmental health services from infancy to adolescence. The platform serves as a marketplace, offering a simplified path to care by matching families with Coral Care’s team of trusted, local, in-networkpediatric specialists available for in-person and in-home sessions.Coral Care’s platform provides pediatric specialists with the infrastructure needed to grow their private practices and deliver quality in-person care. The company offers administrative support and tools, content, credentialing services, and marketing services, which enable pediatric specialists to focus on care, not managing their businesses. $13M / Series A / Feb 23, 2026
Primum is a digital platform that connects general oncologists to subspecialist oncologists for help on their most complex cases. Seed / Sep 25, 2025
Our healthcare system assumes we make decisions based on what is best for us. But it’s not that simple. Everyday stressors often cloud our judgement as to what’s best in the long run. For people with chronic conditions, this can make healthy habit formation difficult. Wellth is a venture-backed digital health company that improves adherence inchronic disease populations. Using the science of behavioral economics—combined with an appreciation for human nature—we uncover and address the unique obstacles that prevent people with chronic conditions from improving patient outcomes. Our program goes beyond current efforts to boost adherence with technology, reminders, and coaching solutions using contingency management and loss aversion to create motivation, behavior change and improve population health at scale.In addition to our RCT-proven outcomes, our easy-to-use mobile platform experience has been proven by health plans, providers, and other organizations to empower members with the incentives and support system they need to establish new healthy habits. Key outcomes for members include improved med and care plan adherence, reduction in readmissions, hospitalizations, and ED utilization, improved PDC, and more. Learn more at www.wellthapp.com. $36M / Series C / Aug 20, 2025
Ignite is the UK’s leading provider of technology-driven Patient Recruitment and Real-World Evidence solutions. $10.9M / Series A / Aug 14, 2025
EvolvedMD is leading the integration of behavioral health services in modern primary care. $34M / Series B / Jul 14, 2025
Vellum Health platform provides on-demand IV enablement & treatment optimized for provider organizations, payers, clinicians, and patients. Series A / Jun 26, 2025
Posterity Health educate, engage, and encourage couples to approach the conception process together as an integrated unit. Posterity Health is the only digital male fertility platform that empowers men to learn about their partner's fertility and take action. $17M / Series A / Feb 18, 2025
KODE Health is an on-demand medical coding solution for maximum flexibility, quality, and control for systems and Koders alike. KODE is a health-tech company seeking to break the traditional model of medical coding and created the first and only on-demand platform that connects healthcare providers and coders in real time. Its headquarters islocated in Holland, Michigan. $27M / Series B / Jan 30, 2025
See all 92 investments →

Co-Investors

Access 48,091 investors

822 industries, 177 countries. Updated daily. Emails and phones included.

Browse database — It's Free!

Find investors for your startup

Search 48,091 investors by industry and country. Emails and phones included.

Any industry
Video Games
Hospitality
EdTech
Restaurants
Google
Construction
Photography
Cryptocurrency
Clean Energy
CleanTech
Big Data
Email
Artificial Intelligence
Social Impact
SaaS
Energy
Mobile
Consumer
Health Care
Enterprise Software
Local
Platforms
InsurTech
Travel
Film
Oil and Gas
Retail
Payments
Marketplace
Fitness
Organic Food
Machine Learning
Agriculture (AgTech)
Gaming
Facebook
Blockchain
B2B
Social Network
Medical Device
Education
Wellness
Sports
Automotive
eSports
Legal
Software
Biotechnology
Renewable Energy
Crowdfunding
Venture Capital
Social
Infrastructure
Beauty
Fashion
Climate
LGBT
Cannabis
Celebrity
Life Science
Food and Beverage
Publishing
Mobile Apps
Wine and Spirits
Music
Art
Real Estate
Sporting Goods
Recruiting
Manufacturing
FinTech
Finance
Digital Media
Social Media
Financial Services
Franchise
Non Profit
Internet
Mobile Advertising
Android
Proptech
Impact
Sustainability
Hardware
Biotech
Transportation
Enterprise
Community
Media (Entertainment)
Web3
Medical
Theatre
Any country
Afghanistan
Greece
United Kingdom
Thailand
United Arab Emirates
Andorra
Benin
South Korea
Japan
Burkina Faso
Africa
Singapore
Brazil
LATAM
Gibraltar
Egypt
Taiwan
Zimbabwe
Tunisia
Sweden
Oceania
Hong Kong
Nigeria
Togo
Croatia
Iran
Guinea
Haiti
Kyrgyzstan
Norway
Lesotho
Liberia
Isle of Man
Malawi
Mexico
Nepal
Madagascar
Russian Federation
Sudan
Pakistan
Tajikistan
Zambia
Romania
Oman
Poland
Puerto Rico
Cameroon
Guernsey
Colombia
China
Armenia
Costa Rica
Kenya
Czech Republic
Kuwait
Marshall Islands
Luxembourg
Malta
Mozambique
Namibia
Mauritius
Nicaragua
Panama
Serbia
Uzbekistan
New Zealand
Australia
Saudi Arabia
Sri Lanka
Jamaica
Guatemala
Morocco
Switzerland
Kazakhstan
Cayman Islands
Venezuela
Myanmar
Turkey
Uganda
Uruguay
Moldova
Seychelles
Botswana
Canada
Paraguay
South Africa
France
Ireland
Denmark
Georgia
Ghana
Iraq
Latvia
Malaysia
Mali
Philippines
Portugal
Rwanda
El Salvador
Sierra Leone
Tanzania
Senegal
United States
India
Germany
Middle East
Indonesia
Asia
Dominican Republic
Bermuda
Albania
Spain
Argentina
Europe
Qatar
Angola
Cyprus
Bangladesh
Barbados
Belgium
Jordan
Ethiopia
Austria
Azerbaijan
Bulgaria
Faroe Islands
Jersey
Bahrain
Ecuador
Bolivia
Estonia
Belize
Algeria
Italy
Belarus
Finland
Bahamas
Hungary
Grenada
Israel
Lithuania
Liechtenstein
Honduras
Iceland
Cambodia
Lebanon
Mongolia
Peru
Slovenia
San Marino
Ukraine
Chile
Vietnam
Angel Investors
VC Funds
All Investors

Similar Investors

Recommended lists

FAQ

What does FCA Venture Partners invest in?

FCA Venture Partners invests primarily in Health Care, Software and Medical startups, most often at Series A and Series B stage. Most of the 92 investments tracked by Shizune back companies in United States. The Investment Focus section breaks down every industry, stage and country in the portfolio.

What is FCA Venture Partners's check size?

FCA Venture Partners typically joins rounds of $3M–$17M at Series A and $3M–$27M at Series B. These ranges are 10th–90th percentile round sizes calculated from confirmed public funding rounds, so they are a realistic guide to the rounds FCA Venture Partners participates in.

How do I contact FCA Venture Partners?

Public channels for FCA Venture Partners include LinkedIn and the website linked on this profile. For a verified work email and phone number, create a free Shizune account — contact data is searched across 20+ sources and validated before delivery, so your outreach lands in the right inbox.

Who are the partners at FCA Venture Partners?

The team at FCA Venture Partners includes Andrew Bouldin (Partner), George Curran (Associate) and John R. Burch (Managing Partner), among 8 team members tracked by Shizune. The Team section lists each member with their title, investment count and links.

Is Shizune's investor data accurate?

Yes — every stat on this profile is calculated from confirmed public funding rounds monitored across hundreds of sources since 2020. This profile was last refreshed in Aug 2026 and is updated monthly. Spotted something off? Use the “Suggest an edit” link near the top of the page.

Contact your first 100 investors today

Find who invests in your industry, stage, and country. Download investor list with emails in 5 minutes.

Find investors — It's Free!
FCA Venture Partners FCA Venture Partners Find emails